Defence Finance Monitor applies a top–down method that traces how NATO, EU and allied strategic priorities are translated into regulations, funding lines and procurement programmes, and then into demand for specific capabilities, technologies and companies. We use official doctrine as the organising frame to identify where strategic relevance is being institutionally defined and where it is materialising in concrete budgets, acquisition pathways and industrial capacity.
Our working assumption is that what becomes structurally relevant in NATO/EU strategy tends, over time, to become relevant also from a financial and industrial point of view. In the European context, this includes the progressive operationalisation of strategic autonomy: the effort to reduce critical dependencies, secure supply chains, strengthen the European defence technological and industrial base, and align regulatory, financial and procurement instruments with long-term security objectives. On this basis, DFM operates as a decision-support tool: it benchmarks investment and industrial choices against institutional demand, clarifies which capabilities are rising on the spending agenda, and maps the funding instruments, eligibility constraints and supply-chain factors that shape real-world feasibility across investors, industry, public authorities and research organisations.
Defence Finance Monitor rests on a single analytical premise: within the Euro-Atlantic security architecture, strategic doctrine precedes regulation and capability planning, regulation precedes budgets, and budgets shape markets.
Europe’s Missile Constraint
Why deep strike, anti-ballistic defence and complex-weapon production are becoming central to European rearmament
Europe’s rearmament is moving beyond the first lesson of the drone war. Inexpensive unmanned systems remain essential for reconnaissance, saturation, attrition and low-cost interception, but they cannot reproduce every military effect. Cruise missiles, ballistic missiles and high-performance interceptors remain necessary against hardened targets, at operational depth and against the most demanding incoming threats. The resulting constraint is increasingly one of magazine depth: how many complex weapons European forces can hold, replace and command at the rate a sustained high-intensity campaign would consume them.
European procurement is beginning to reflect that hierarchy. Long-range strike programmes now distinguish between low-cost one-way effectors and several classes of missiles, while air defence is being structured around different interceptors for different threats. The industrial consequences extend well below final assembly. Propulsion, energetic materials, inertial navigation, seekers, radar, data links, command systems and qualification capacity increasingly determine how quickly additional orders can become usable weapons. Europe is therefore trying to build mass at several levels of technological complexity at once, and the most consequential bottlenecks may sit upstream of the missile manufacturers whose names dominate procurement announcements.
European Defence Cooperation after the Ottawa Withdrawals
Who may lawfully supply, finance and insure a capability that five European states have chosen and eight others still prohibit
Estonia, Latvia, Lithuania, Finland and Poland have ceased to be bound by the Ottawa Convention’s prohibition on antipersonnel mines. That decision gives those states greater freedom to develop, acquire and field the capability. It does not give companies, engineers, financial institutions or insurers in countries that remain parties equivalent freedom to participate. The resulting European industrial landscape is therefore legally fragmented: the customer may lawfully procure a weapon while potential suppliers elsewhere remain subject to domestic prohibitions on production, components, technological assistance or transfer.
Finance and insurance create a separate set of boundaries. Italian law prohibits specified forms of financing for companies involved in antipersonnel mines, while major European insurers and asset managers maintain exclusions for convention-banned weapons even as broader restrictions on defence investment have been relaxed. The programmes emerging in Poland, Finland and Lithuania consequently point towards more nationally contained supply chains. The relevant question for European defence cooperation is no longer simply whether governments agree on a military requirement, but whether the industrial, technological and financial relationships needed to realise it remain legally available across jurisdictions.
Medical Oxygen and the Redundancy Rule for Europe’s Deployable Hospitals
Why on-site generation of oxygen 93 cannot satisfy the three-source requirement alone
Generating medical oxygen inside a deployed hospital can substantially reduce the volume of compressed gas that must be transported into theatre. It does not eliminate the requirement for external supply. European medical-gas standards require three sources of oxygen capable of sustaining the facility, and at least one must be independent of the electrical supply. A pressure-swing adsorption plant, its second production line and cylinders refilled from that same electrically powered system therefore do not necessarily provide three independent sources, even when generators and compressors themselves are duplicated.
That changes what constitutes a complete deployable oxygen capability. Procurement must account not only for the generating plant but also for an electrically independent reserve, analysers and continuous quality monitoring, commissioning and qualification, spare parts, pressure-vessel inspection, trained personnel and the procedures required to return the system to pharmaceutical service after maintenance. On-site generation remains operationally attractive, but the relevant saving is the amount of transported oxygen it can safely displace while the mandatory independent reserve remains intact. A generating container is equipment; the capability is the complete, redundant and continuously qualified supply system around it.
Patent Secrecy and the Commercialisation of European Defence Technology
National filing controls, restricted disclosure and cross-border licensing in France, Germany and Italy
A defence-technology company can own an invention and still lack immediate freedom to file it abroad, disclose its technical content to an investor or manufacturing partner, or license it across borders. France, Germany and Italy preserve different national security controls over these acts, and neither the European Patent Convention nor the Patent Cooperation Treaty overrides them. The relevant constraint therefore appears before commercialisation is complete: moving technical information across a corporate group or opening a data room may itself require a public-law permission that ownership of the patent does not provide.
The three systems take different routes. France imposes an initial restriction on disclosure and exploitation but provides explicit mechanisms for authorising assignments, licences and foreign filings. Germany focuses on inventions containing state secrets and separates patent ownership from the criminal-law restrictions governing protected information. Italy applies a foreign-filing gate to inventions potentially useful for national defence and extends it to circumstances involving foreign corporate groups and pre-filing assignments. For defence companies, investors and research consortia, the practical requirement is to treat permission to communicate as a separate condition from title, contractual confidentiality and the right to commercialise.
Understanding European Defence as a System
The four cases concern very different parts of European rearmament, but they reveal the same underlying distinction between possessing an asset and possessing a usable capability. A missile programme depends on upstream production that cannot be inferred from the number of launchers ordered. A government’s legal freedom to procure a weapon does not give foreign suppliers or financiers the same freedom to support it. An oxygen generator does not by itself satisfy the redundancy and pharmaceutical requirements of a military hospital. Ownership of intellectual property does not necessarily include permission to disclose or license the underlying technology.
Defence Finance Monitor connects these layers. It follows strategic requirements through law, finance, procurement, technology, industrial organisation, infrastructure and supply chains to determine what governments, companies, advisers and investors can actually rely on.
For companies, this means understanding not only where demand is increasing, but what legal, industrial and technical conditions determine whether that demand can be served. For legal and strategic advisers, it means connecting rules to their consequences for production, transactions and operational capacity. For investors and lenders, it means distinguishing announced programmes and market opportunity from the bottlenecks, rights and dependencies that determine whether capital can become usable defence capability.
A subscription provides access to the complete analyses and the full Defence Finance Monitor research archive.